Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053640226> ?p ?o ?g. }
- W2053640226 endingPage "298" @default.
- W2053640226 startingPage "291" @default.
- W2053640226 abstract "Lipopolysaccharide (LPS), an endotoxin of Gram-negative bacteria, activates the innate immunity system through a receptor complex of myeloid differentiation 2 (MD-2) and toll-like receptor 4 (TLR4). MD-2 directly recognizes the lipid A domain of LPS, which triggers MD-2/TLR4-mediated cellular response aimed at eliminating the invaded pathogen. However, excess production of inflammatory mediators is harmful to host tissue and this can cause septic death in extreme cases. MD-2 represents an attractive therapeutic target of inflammatory and immune diseases in human. In particular, eritoran is a synthetic tetraacylated lipid A that binds directly to MD-2 and antagonizes LPS binding to the same site, and it ameliorates various inflammatory conditions due to infection or sterile organ injury. In this review, we outline the recent advances in the structure biology of ligand interaction with MD-2/TLR4, and highlight the MD-2-directed LPS antagonists, which are natural and synthetic chemicals, under development to treat inflammatory diseases." @default.
- W2053640226 created "2016-06-24" @default.
- W2053640226 creator A5034557143 @default.
- W2053640226 creator A5037204409 @default.
- W2053640226 creator A5049032346 @default.
- W2053640226 creator A5049902585 @default.
- W2053640226 creator A5056807127 @default.
- W2053640226 creator A5087838333 @default.
- W2053640226 date "2012-03-01" @default.
- W2053640226 modified "2023-09-24" @default.
- W2053640226 title "Myeloid differentiation 2 as a therapeutic target of inflammatory disorders" @default.
- W2053640226 cites W127606149 @default.
- W2053640226 cites W1483162601 @default.
- W2053640226 cites W1532387244 @default.
- W2053640226 cites W1542029261 @default.
- W2053640226 cites W1551551630 @default.
- W2053640226 cites W1556913350 @default.
- W2053640226 cites W1791487694 @default.
- W2053640226 cites W1963869935 @default.
- W2053640226 cites W1970216382 @default.
- W2053640226 cites W1973278848 @default.
- W2053640226 cites W1975252654 @default.
- W2053640226 cites W1975795041 @default.
- W2053640226 cites W1978093013 @default.
- W2053640226 cites W1988188360 @default.
- W2053640226 cites W1988510020 @default.
- W2053640226 cites W1997149430 @default.
- W2053640226 cites W2003671495 @default.
- W2053640226 cites W2010872522 @default.
- W2053640226 cites W2023990659 @default.
- W2053640226 cites W2028226782 @default.
- W2053640226 cites W2028556682 @default.
- W2053640226 cites W2034222489 @default.
- W2053640226 cites W2045417011 @default.
- W2053640226 cites W2048569145 @default.
- W2053640226 cites W2050262218 @default.
- W2053640226 cites W2053189438 @default.
- W2053640226 cites W2056812842 @default.
- W2053640226 cites W2057554913 @default.
- W2053640226 cites W2057967701 @default.
- W2053640226 cites W2062835892 @default.
- W2053640226 cites W2063585986 @default.
- W2053640226 cites W2064077721 @default.
- W2053640226 cites W2065053912 @default.
- W2053640226 cites W2066318573 @default.
- W2053640226 cites W2073565085 @default.
- W2053640226 cites W2078349383 @default.
- W2053640226 cites W2086676026 @default.
- W2053640226 cites W2087867048 @default.
- W2053640226 cites W2105778142 @default.
- W2053640226 cites W2106023265 @default.
- W2053640226 cites W2119518338 @default.
- W2053640226 cites W2124438200 @default.
- W2053640226 cites W2126719418 @default.
- W2053640226 cites W2126789189 @default.
- W2053640226 cites W2127934565 @default.
- W2053640226 cites W2128897591 @default.
- W2053640226 cites W2129319296 @default.
- W2053640226 cites W2130187320 @default.
- W2053640226 cites W2130655121 @default.
- W2053640226 cites W2130840482 @default.
- W2053640226 cites W2131943372 @default.
- W2053640226 cites W2132413368 @default.
- W2053640226 cites W2138124218 @default.
- W2053640226 cites W2138167941 @default.
- W2053640226 cites W2140040520 @default.
- W2053640226 cites W2141190067 @default.
- W2053640226 cites W2141476186 @default.
- W2053640226 cites W2145955453 @default.
- W2053640226 cites W2146948320 @default.
- W2053640226 cites W2149656250 @default.
- W2053640226 cites W2149697611 @default.
- W2053640226 cites W2157928866 @default.
- W2053640226 cites W2161681729 @default.
- W2053640226 cites W2950442133 @default.
- W2053640226 cites W300817169 @default.
- W2053640226 cites W4230567930 @default.
- W2053640226 doi "https://doi.org/10.1016/j.pharmthera.2011.11.001" @default.
- W2053640226 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22119168" @default.
- W2053640226 hasPublicationYear "2012" @default.
- W2053640226 type Work @default.
- W2053640226 sameAs 2053640226 @default.
- W2053640226 citedByCount "50" @default.
- W2053640226 countsByYear W20536402262012 @default.
- W2053640226 countsByYear W20536402262013 @default.
- W2053640226 countsByYear W20536402262014 @default.
- W2053640226 countsByYear W20536402262015 @default.
- W2053640226 countsByYear W20536402262016 @default.
- W2053640226 countsByYear W20536402262017 @default.
- W2053640226 countsByYear W20536402262018 @default.
- W2053640226 countsByYear W20536402262019 @default.
- W2053640226 countsByYear W20536402262020 @default.
- W2053640226 countsByYear W20536402262021 @default.
- W2053640226 countsByYear W20536402262022 @default.
- W2053640226 countsByYear W20536402262023 @default.
- W2053640226 crossrefType "journal-article" @default.
- W2053640226 hasAuthorship W2053640226A5034557143 @default.
- W2053640226 hasAuthorship W2053640226A5037204409 @default.